J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

"We talk about the S-curve for technology and in the past we've said it can be 10 or 20 years before you reach the top. I think what's going to be really different about AI is that time frame is going ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Sheryl Lee Ralph is putting another film with Denzel Washington on her career bucket list. "Denzel and I did a film called The Mighty Quinn, and that was right before he became Denzel," the Abbott ...

When you speak with Sheryl Lee Ralph, it’s hard to believe that this is her first time living life like the rest of us. She ...

Shares of GSK PLC GSK inched up 0.94% to £14.01 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,557.81. GSK ...

On the second anniversary of her daughter Lisa Marie Presley’s sudden death at age 54, Priscilla Presley posted a heartfelt ...

Vaccine stocks in focus as RFK Jr., a notable vaccine skeptic and President Trump’s nominee to lead the HHS, faces a Senate ...